TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,913
|
10,944
|
9,221 |
Financial expenses |
36
|
45
|
19 |
Earnings before taxes |
2,771
|
2,855
|
2,095 |
EBITDA |
2,741
|
2,894
|
2,114 |
Total assets |
7,526
|
6,084
|
4,376 |
Current assets |
7,427
|
6,045
|
4,327 |
Current liabilities |
2,398
|
2,517
|
1,694 |
Equity capital |
87
|
85
|
91 |
- share capital |
5
|
4
|
5 |
Employees (average) |
4
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.2%
|
1.4%
|
2.1% |
Turnover per employee |
3,478
|
3,648
|
3,074 |
Profit as a percentage of turnover |
19.9%
|
26.1%
|
22.7% |
Return on assets (ROA) |
37.3%
|
47.7%
|
48.3% |
Current ratio |
309.7%
|
240.2%
|
255.4% |
Return on equity (ROE) |
3185.1%
|
3358.8%
|
2302.2% |
Change turnover |
2,937
|
2,470
|
1,189 |
Change turnover % |
27%
|
29%
|
15% |
Chg. No. of employees |
1
|
0
|
1 |
Chg. No. of employees % |
33%
|
0%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.